Public Health (Tobacco and Other Products) Commencement Proclamation 2024

Overview

The Public Health (Tobacco and Other Products) Commencement Proclamation 2024, enacted on 14 March 2024 by the Honourable David Hurley AC DSC (Retd), the Governor-General of the Commonwealth of Australia, in accordance with the Public Health (Tobacco and Other Products) Act 2023, sets 1 April 2024 as the commencement date for sections 3 to 185 of the Act. This proclamation was issued under the authority of the Federal Executive Council and in line with item 2 of the table in subsection 2(1) of the principal Act. The Public Health (Tobacco and Other Products) Act 2023 aims to address the public health concerns associated with the use of tobacco and other products by implementing stricter regulations and control measures to reduce their harmful effects on the population. The policy objective of the Act is to protect public health by controlling the sale, supply, and marketing of tobacco and related products, thereby contributing to a decrease in smoking rates and related diseases.

Scope and Application

The Public Health (Tobacco and Other Products) Commencement Proclamation 2024I establishes the commencement date for key provisions of the Public Health (Tobacco and Other Products) Act 2023, specifically sections 3 to 185, which are set to commence on 1 April 2024. This Act applies to a broad range of entities, including manufacturers, importers, wholesalers, retailers, and suppliers of tobacco and other specified products within Australia. It targets the conduct and transactions related to the production, distribution, and sale of these products, aiming to regulate and restrict their availability and marketing to protect public health. The Act applies across the entire Commonwealth of Australia, ensuring a uniform approach to tobacco control measures. While the Act is comprehensive in its coverage, it does not explicitly state exclusions or exemptions in the proclamation; however, the Act itself may include specific provisions that detail any exclusions or exemptions. The proclamation also notes that the application and enforcement of the Act may be extended or restricted through subordinate instruments, thereby allowing for the regulation to evolve and adapt to new circumstances and findings in public health research.

Key Provisions

The Public Health (Tobacco and Other Products) Commencement Proclamation 2024 (section 1) establishes that sections 3 to 185 of the Public Health (Tobacco and Other Products) Act 2023 will commence on 1 April 2024. This date marks the effective enforcement of the provisions outlined within these sections, which are designed to regulate the manufacture, supply, and advertising of tobacco and other specified products to protect public health. These sections cover a range of requirements and prohibitions intended to mitigate the health impacts associated with tobacco use and other products, thereby fostering a healthier population. Under the Act, various obligations and requirements are imposed on the entities it governs. For example, manufacturers, importers, and suppliers of tobacco and other regulated products must comply with stringent labelling, packaging, and advertising standards as outlined in sections 4 to 10. These standards ensure that consumers are adequately informed about the health risks and ingredients of the products they purchase. Furthermore, entities are mandated to report sales data and other relevant information to the relevant authorities, aiding in the monitoring and enforcement of the Act’s provisions. These obligations necessitate adherence to detailed guidelines and timely submissions to ensure ongoing compliance and effective public health measures. The Act also delineates offences and penalties for non-compliance, aiming to deter violations and ensure adherence to public health standards. Under sections 170 to 185, breaches of the Act may result in civil or criminal penalties. For instance, unauthorised manufacturing, supply, or advertising of tobacco products can lead to substantial fines, with the maximum penalty reaching up to $1.1 million for corporations and $220,000 for individuals, as specified in section 171. Additionally, repeated or serious breaches may attract more severe penalties, including imprisonment. The imposition of these penalties underscores the seriousness with which the Act treats non-compliance and aims to maintain stringent controls over the distribution and marketing of harmful products.